Director/PDMR Shareholding

RNS Number : 4801B

GlaxoSmithKline PLC

11 February 2022

 

GlaxoSmithKline plc   (the ' Company ')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr B McNamara
b)	Position/status	CEO, GSK Consumer Healthcare
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financialinstrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature ofthe transaction	Sale of 55,000 ADSs
c)	Price(s)and volume(s)	Price(s) Volume(s) $44.9937 55,000
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2022-02-10
f)	Placeofthe transaction	New York Stock Exchange (XNYS)

 

END

 

 

DSHZFLFFLLLBBBF